Video Experimental Relacionado
Updated: Jan 7, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
Piropitosis-impulsada por la desregulación inmunitaria en la EPOC: mecanismos moleculares e implicaciones
Feng-Xian Ni1, Hui-Xian Wang2, Jie Hu1
1Zhuhai Hospital of Integrated Traditional Chinese & Western Medicine, Zhuhai, Guangdong, China.
Frontiers in immunology
|January 1, 2026
Resumen
La piropitosis, una muerte celular programada, impulsa la inflamación en la enfermedad pulmonar obstructiva crónica (EPOC). Dirigirse a este proceso puede ofrecer nuevas estrategias terapéuticas para el manejo de la EPOC y su desregulación inmunitaria asociada.
Área de la Ciencia:
- Inmunología; Biología Celular; Medicina Pulmonar
Sus antecedentes:
- La piropitosis es una vía de muerte celular programada crucial para la inmunidad, pero implicada en la inflamación crónica.
- La piropitosis desregulada contribuye a la patogénesis de enfermedades inflamatorias como la enfermedad pulmonar obstructiva crónica (EPOC).
Objetivo del estudio:
- Revisar los mecanismos moleculares de la piropitosis y su papel en la EPOC.
- Explorar la interacción de la piropitosis con las células inmunitarias en la EPOC.
- Discutir las estrategias de focalización terapéutica para la piropitosis en la EPOC.
Principales métodos:
- Revisión de literatura que sintetiza evidencia de investigación primaria.
- Análisis de los mecanismos moleculares de la activación de la piropitosis.
- Examen de los roles específicos de la piropitosis en tipos celulares en la EPOC.
Principales resultados:
- La piropitosis, mediada por proteínas gasdermina, se activa por los inflamasomas.
- La piropitosis excesiva exacerba la inflamación y el daño tisular en la EPOC.
- La piropitosis influye en la desregulación inmunitaria que involucra a neutrófilos, macrófagos y linfocitos T en la EPOC.
Conclusiones:
- La comprensión de la piropitosis es clave para abordar la desregulación inmunitaria en la EPOC.
- La focalización de la piropitosis presenta una vía terapéutica prometedora para el manejo de la EPOC.
- La investigación adicional sobre los mecanismos de la piropitosis puede conducir a estrategias de tratamiento novedosas.
Videos de Conceptos Relacionados
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
698
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
698
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K